ArticleBiologics : targets & therapy2016

Tocilizumab in refractory rheumatoid arthritis: long-term efficacy, safety, and tolerability beyond 2 years.

Ziad Farah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.